Design Therapeutics Inc (DSGN)

SG&A Expenses

$20.58M

TTM · Period ending: · USD

DSGN logo

DSGN SG&A Expenses

Latest reported$20.58M
DSGN TTM SG&A Expenses ($2.50M → $20.58M)
High-resolution chart · PNG

DSGN sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Design Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
20,582,000
20,624,000
20,338,000
20,131,000
19,779,000
18,475,000
18,033,000
17,605,000
18,800,000
19,805,000
21,127,000
22,155,000
21,478,000
20,290,000
18,980,000
17,633,000
15,543,000
13,859,000
11,053,000
8,449,000
6,140,000
3,913,000
2,496,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.